X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210908006073/en/Calypso-Biotech-Announces-First-Patient-With-Celiac-Disease-Dosed-in-anti-Interleukin-15-IL-15-Monoclonal-Antibody-CALY-002-Phase-1b-Trial-and-Extension-of-Series-A-to-%E2%82%AC28M